Cardiff Oncology (CRDF) EPS (2012 - 2026)
Cardiff Oncology (CRDF) EPS from Mar 31, 2012 to Mar 31, 2026. The TTM Cardiff Oncology (CRDF) EPS is -$0.66. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Cardiff Oncology (CRDF) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -24.65% |
| 3 Years TTM | -9.14% |
| 5 Years TTM | -0.54% |
| 10 Years TTM | -20.48% |
| All Time TTM | -18.33% |
Annual EPS change of Cardiff Oncology (CRDF)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.18 | -73.11% |
| 2025 | -$0.67 | -1.71% |
| 2024 | -$0.68 | -26.37% |
| 2023 | -$0.93 | +7.08% |
| 2022 | -$0.87 | +28.49% |
| 2021 | -$0.67 | +28.41% |
| 2020 | -$0.52 | +64.93% |
| 2019 | -$0.32 | -53.10% |
| 2018 | -$0.68 | -84.78% |
| 2017 | -$4.46 | -42.45% |
| 2016 | -$7.75 | -3.62% |
| 2015 | -$8.04 | -11.68% |
| 2014 | -$9.10 | +9.24% |
| 2013 | -$8.33 | -13.30% |
| 2012 | -$9.61 | N/A |
Comparison Cardiff Oncology (CRDF) five years EPS CAGR with competitors
Cardiff Oncology (CRDF) five years EPS CAGR is -0.54%.